SEQSTER and PatientsLikeMe Launch National Rare Disease Study


SEQSTER and PatientsLikeMe (PLM) have collaborated to launch a rare-disease study focused on Alpha-1 Antitrypsin Deficiency (AATD). The study aims to better understand how to reduce delays in diagnosis, decrease disparities in care, and improve outcomes in patients with AATD.

Read more about the study here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.